These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Serum erythropoietin levels and bone marrow hematopoiesis in patients with aplastic anemia]. Ogawa T Rinsho Ketsueki; 1996 Jul; 37(7):604-9. PubMed ID: 8779780 [TBL] [Abstract][Full Text] [Related]
4. [Clinical usefulness of measurement of erythropoietin in blood]. Yoshida Y; Hara H; Takahashi Y; Yamaguchi N; Kawagoe H; Shibata H; Ohno Y; Teshima H Rinsho Ketsueki; 1993 Aug; 34(8):895-903. PubMed ID: 8411644 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietin response to anaemia in children with sickle cell disease and Fanconi's hypoproliferative anaemia. McGonigle RJ; Ohene-Frempong K; Lewy JE; Fisher JW Acta Haematol; 1985; 74(1):6-9. PubMed ID: 3934912 [TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation. Locatelli F; Pedrazzoli P; Barosi G; Zecca M; Porta F; Liberato L; Gambarana D; Nespoli L; Cazzola M Br J Haematol; 1992 Apr; 80(4):545-9. PubMed ID: 1581240 [TBL] [Abstract][Full Text] [Related]
7. Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias. Das RE; Milne A; Rowley M; Smith EC; Cotes PM Br J Haematol; 1992 Nov; 82(3):601-7. PubMed ID: 1486041 [TBL] [Abstract][Full Text] [Related]
8. Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. Beguin Y; Clemons GK; Oris R; Fillet G Blood; 1991 Feb; 77(4):868-73. PubMed ID: 1847085 [TBL] [Abstract][Full Text] [Related]
9. Changes in serum erythropoietin levels during allogeneic bone marrow transplantation. Grace RJ; Kendall RG; Chapman C; Hartley AE; Barnard DL; Norfolk DR Eur J Haematol; 1991 Aug; 47(2):81-5. PubMed ID: 1889486 [TBL] [Abstract][Full Text] [Related]
10. Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting. Lazarus HM; Goodnough LT; Goldwasser E; Long G; Arnold JL; Strohl KP Bone Marrow Transplant; 1992 Jul; 10(1):71-5. PubMed ID: 1515882 [TBL] [Abstract][Full Text] [Related]
11. Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation. Abedi MR; Bäckman L; Boström L; Lindbäck B; Ringdén O Bone Marrow Transplant; 1990 Aug; 6(2):121-6. PubMed ID: 2207449 [TBL] [Abstract][Full Text] [Related]
12. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. Socié G; Henry-Amar M; Bacigalupo A; Hows J; Tichelli A; Ljungman P; McCann SR; Frickhofen N; Van't Veer-Korthof E; Gluckman E N Engl J Med; 1993 Oct; 329(16):1152-7. PubMed ID: 8377778 [TBL] [Abstract][Full Text] [Related]
13. Circulating erythropoietin in patients with myelodysplastic syndromes. Jacobs A; Janowska-Wieczorek A; Caro J; Bowen DT; Lewis T Br J Haematol; 1989 Sep; 73(1):36-9. PubMed ID: 2803975 [TBL] [Abstract][Full Text] [Related]
14. Aplastic anaemia in childhood: a reappraisal. II. Idiopathic and acquired aplastic anaemia. Hughes DW Med J Aust; 1973 Aug; 2(8):361-6. PubMed ID: 4749526 [No Abstract] [Full Text] [Related]
15. Regulation of erythropoietin and burst-promoting activity production in patients with aplastic anemia and iron deficiency anemia. Takeichi N; Umemura T; Nishimura J; Motomura S; Kozuru M; Ibayashi H Acta Haematol; 1988; 80(3):145-52. PubMed ID: 3143213 [TBL] [Abstract][Full Text] [Related]
16. A plasma microRNA signature as a biomarker for acquired aplastic anemia. Hosokawa K; Kajigaya S; Feng X; Desierto MJ; Fernandez Ibanez MD; Rios O; Weinstein B; Scheinberg P; Townsley DM; Young NS Haematologica; 2017 Jan; 102(1):69-78. PubMed ID: 27658437 [TBL] [Abstract][Full Text] [Related]
17. Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Schapira L; Antin JH; Ransil BJ; Antman KH; Eder JP; McGarigle CJ; Goldberg MA Blood; 1990 Dec; 76(11):2354-9. PubMed ID: 2257306 [TBL] [Abstract][Full Text] [Related]
18. Circulating erythropoietin levels in pathophysiological conditions. Noé G; Schrezenmeier H; Rich IN; Kubanek B Ann N Y Acad Sci; 1994 Apr; 718():94-101; discussion 101-2. PubMed ID: 8185255 [No Abstract] [Full Text] [Related]
19. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center]. van Steekelenburg M; van Weel-Sipman MH; Zwinderman AH; Hoogerbrugge PM; Vossen JM; Egeler RM Ned Tijdschr Geneeskd; 2002 Aug; 146(33):1542-6. PubMed ID: 12212502 [TBL] [Abstract][Full Text] [Related]
20. Aetiology of severe aplastic anaemia and outcome after allogeneic bone marrow transplantation or immunosuppression therapy. Working Party on Severe Aplastic Anaemia of the European Blood and Marrow Transplantation Group. Bacigalupo A Eur J Haematol Suppl; 1996; 60():16-9. PubMed ID: 8987236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]